About Masimo
Masimo Rainbow SET Pulse CO-Oximetry
Masimo Rainbow Acoustic Monitoring
Masimo SET Pulse Oximetry
General Floor Monitoring
OEM Products and Solutions
Clinical Validation
Masimo News
Investor Information
Careers with Masimo
Contact Masimo
Masimo U
2009 Masimo Annual Report

> Back to Nellcor Fiction Home

NELLCOR FICTION:

"Nellcor performs just as well as Masimo during patient motion and low perfusion."

FACTS:

  • Eighty-six independent and objective studies conclude that Masimo significantly outperforms Nellcor during patient motion and low perfusion.
  • To the best of Masimo’s knowledge, not a single published study concludes that currently available Nellcor technology (N-600/N-600x) performs as well or better than Masimo technology during conditions of motion and low perfusion.
  • Masimo's superiority is easy to see in side-by-side demonstrations. Masimo encourages real-world, head-to-head clinical evaluations of its technology against any other pulse oximetry technology. In Masimo’s experience, Nellcor avoids head-to-head comparisons, especially ones that are objectively documented with automated data collection systems.
  • Masimo offers hospitals a Performance Superiority Guarantee that Masimo pulse oximeters will outperform Nellcor oximeters on challenging patients. Masimo recently raised this guarantee to $1 Million.

PROOF:

GUARANTEE:

Masimo SET $1,000,000 Performance Guarantee:
In keeping with Masimo's mission to improve patient care, and to help clinicians separate fact from fiction, Masimo is renewing and expanding its performance guarantee. If Masimo SET is proven not to be more accurate than Nellcor OxiMax/N-600x pulse oximetry during motion artifact and low perfusion, we will pay up to $1,000,000 to help your hospital acquire that pulse oximetry.